104 related articles for article (PubMed ID: 3392657)
21. Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
Grover GJ; Fulmor IE
J Pharmacol Exp Ther; 1988 Nov; 247(2):445-52. PubMed ID: 3183946
[TBL] [Abstract][Full Text] [Related]
22. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1984 Mar; 228(3):531-6. PubMed ID: 6707908
[TBL] [Abstract][Full Text] [Related]
23. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
Grover GJ; Schumacher WA; Simon M; Parham C
J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
[TBL] [Abstract][Full Text] [Related]
24. The effects of a critical stenosis on myocardial blood flow, ventricular function, and infarct size after coronary reperfusion.
Lefkowitz CA; Pace DP; Gallagher KP; Buda AJ
Circulation; 1988 Apr; 77(4):915-26. PubMed ID: 3349586
[TBL] [Abstract][Full Text] [Related]
25. Effect of activation of ATP-dependent potassium channels with (-)-pinacidil and (-)-3-pyridyl pinacidil on infarct size in a canine model of ischemia-reperfusion injury.
Smallwood JK; Schelm JA; Bemis KG; Simpson PJ
J Cardiovasc Pharmacol; 1993 Nov; 22(5):731-43. PubMed ID: 7506326
[TBL] [Abstract][Full Text] [Related]
26. Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart.
Higginson L; Tang A; Knoll G; Calvin J
J Am Coll Cardiol; 1991 Sep; 18(3):868-75. PubMed ID: 1869751
[TBL] [Abstract][Full Text] [Related]
27. [Effect of dobutamine and diltiazem on the reperfused ischemic myocardium].
Oshima N
Nihon Geka Gakkai Zasshi; 1987 Feb; 88(2):143-51. PubMed ID: 3574272
[TBL] [Abstract][Full Text] [Related]
28. The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts.
Klein HH; Schubothe M; Nebendahl K; Kreuzer H
Circulation; 1984 May; 69(5):1000-5. PubMed ID: 6705155
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effect of diltiazem on ischemia-reperfusion injury in the dog.
Kinoshita M; Bito K; Mashiro I; Mitsunami K; Fukuhara T; Kawakita S
Jpn Circ J; 1985 Feb; 49(2):179-89. PubMed ID: 3974124
[TBL] [Abstract][Full Text] [Related]
30. Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium.
Rousseau G; St-Jean G; Latour JG; Merhi Y; Nattel S; Waters D
Cardiovasc Res; 1991 Apr; 25(4):319-29. PubMed ID: 1884391
[TBL] [Abstract][Full Text] [Related]
31. Assessment of residual coronary stenoses using 99mTc-N-NOET vasodilator stress imaging to evaluate coronary flow reserve early after coronary reperfusion in a canine model of subendocardial infarction.
Takehana K; Beller GA; Ruiz M; Petruzella FD; Watson DD; Glover DK
J Nucl Med; 2001 Sep; 42(9):1388-94. PubMed ID: 11535730
[TBL] [Abstract][Full Text] [Related]
32. Combined adenosine and lidocaine administration limits myocardial reperfusion injury.
Homeister JW; Hoff PT; Fletcher DD; Lucchesi BR
Circulation; 1990 Aug; 82(2):595-608. PubMed ID: 2372906
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of salvage of reperfused ischemic myocardium by diltiazem.
Knabb RM; Rosamond TL; Fox KA; Sobel BE; Bergmann SR
J Am Coll Cardiol; 1986 Oct; 8(4):861-71. PubMed ID: 3489747
[TBL] [Abstract][Full Text] [Related]
34. Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion.
Garcia-Dorado D; Théroux P; Solares J; Alonso J; Fernandez-Avilés F; Elizaga J; Soriano J; Botas J; Munoz R
Am J Pathol; 1990 Aug; 137(2):301-11. PubMed ID: 2386198
[TBL] [Abstract][Full Text] [Related]
35. Improvement of reduced coronary vasodilatory response during reactive hyperemia by diltiazem.
Saito D; Ueeda M; Yamada N; Hina K; Watanabe H; Mima T; Hasui M; Kusachi S; Haraoka S; Tsuji T
Arzneimittelforschung; 1989 Apr; 39(4):440-5. PubMed ID: 2502126
[TBL] [Abstract][Full Text] [Related]
36. Reduction in myocardial infarct size by the new potassium channel opener bimakalim.
Auchampach JA; Gross GJ
J Cardiovasc Pharmacol; 1994 Apr; 23(4):554-61. PubMed ID: 7516004
[TBL] [Abstract][Full Text] [Related]
37. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion.
Gallagher KP; Buda AJ; Pace D; Gerren RA; Shlafer M
Circulation; 1986 May; 73(5):1065-76. PubMed ID: 3698229
[TBL] [Abstract][Full Text] [Related]
38. Differential enhancement of postischemic segmental systolic thickening by diltiazem.
Taylor AL; Golino P; Eckels R; Pastor P; Buja LM; Willerson JT
J Am Coll Cardiol; 1990 Mar; 15(3):737-47. PubMed ID: 2303644
[TBL] [Abstract][Full Text] [Related]
39. Diltiazem reduced infarct size but not ventricular arrhythmias in 48 hour coronary embolized dogs.
Yoshida S; Downey JM; Yellon DM; Miura T; Iimura O
Can J Cardiol; 1985; 1(5):346-53. PubMed ID: 3842096
[TBL] [Abstract][Full Text] [Related]
40. Infarct size reduction with coronary venous retroinfusion of diltiazem in the acute occlusion/reperfusion porcine heart model.
Tadokoro H; Miyazaki A; Satomura K; Rydén L; Kaul S; Kar S; Corday E; Drury K
J Cardiovasc Pharmacol; 1996 Jul; 28(1):134-41. PubMed ID: 8797147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
